How do I buy Schrodinger, Inc. Common Stock (SDGR) stock?

Buying Schrodinger, Inc. Common Stock (SDGR) stock is now easy and instant through the Gotrade app. Download the Gotrade app from the App Store or Google Play. Create an account and verify your identity. Make a deposit. Search for the code "SDGR", then tap "Trade". Tap the "Buy" button. Enter the amount you want to buy. You have two options: Buy SDGR by number of shares. Buy fractional shares in dollars, starting from $1. Swipe up to confirm your order, and you're done!

What is the minimum investment for SDGR on Gotrade?

On Gotrade , you don't have to buy a full share. With fractional shares, you can start investing in Schrodinger, Inc. Common Stock from just $1. A small budget shouldn't stop you from building a US stock portfolio.

Does Schrodinger, Inc. Common Stock (SDGR) pay dividends?

At the moment, Schrodinger, Inc. Common Stock (SDGR) does not pay dividends because it focuses on reinvesting profits for company growth (a growth stock). However, you can still potentially earn profit from share price increases (capital gains). Track SDGR's performance via the price chart in the Gotrade app.

Is buying SDGR on Gotrade safe and legal?

Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).

What are the market hours to buy SDGR?

You can place an order any time. It goes through when the US market (NYSE/NASDAQ) opens: 9:30 AM to 4:00 PM New York time, Monday to Friday. Pre-market and after-hours trading are open too. The market is closed on US public holidays. The Gotrade app shows whether the market is open.

How do I tell if SDGR is expensive or cheap?

There's no single perfect answer, but common approaches include: Compare valuation (e.g., P/E, P/S) against historical averages or competitors. Review revenue and earnings growth. Check margins and cash flow. Evaluate business outlook and the company's position within its industry. You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Schrodinger, Inc. Common Stock (SDGR) Stock Price: Nov 11 Close $31.52

News tone: automated (AI) classification of the article's content, not a price prediction.

About Schrodinger, Inc. Common Stock

No description available.

SectorHealthcare

IndustryHealth Information Services

Employees850

CEODr. Ramy Farid Ph.D.

IPO DateFeb 6, 2020

HeadquartersNew York, NY

Key Executives

Name	Title	Year Born
Dr. Ramy Farid Ph.D.	CEO, President & Director	1965
Dr. Richard A. Friesner Ph.D.	Co-Founder, Scientific Advisory Chairman and Director	1953
Mr. Richie Jain	Executive VP, CFO & Treasurer	1985
Mr. Kenneth Patrick Lorton	Executive VP, CTO & COO of Software	1984
Dr. Karen Akinsanya Ph.D.	President, Head of Therapeutics R&D and Chief Strategy Officer & Partnerships	1968
Ms. Yvonne Tran Esq.	Corporate Secretary, Chief Legal & People Officer	1971
Prof. William Goddard III, Ph.D.	Co-Founder & Scientific Advisor	—
Ms. Therese Abrams	Principal Accounting Officer	1984
Mr. Shane Brauner	Executive VP & Chief Information Officer	1977
Ms. Jaren Irene Madden	Chief Corporate Affairs Officer & Head of Investor Relations	—

Fundamentals

Valuation

Price-to-sales ratio9.55

Price-to-book value8.06

Profitability

Return on Equity-18.00%

Return on Assets-9.00%

Return on Sales-21.00%

Gross margin (latest quarter)59.32%

EBITDA$-39.87M

Trading

Average volume1,752,366

Source: third-party data provider, as of November 13, 2026

Technical indicators

RSI 14: 60.42
MACD 12/26/9: 1.53
EMA 9 of MACD: 0.94
MACD histogram: 0.59
SMA 50: $26.55; Price above SMA 50
EMA 50: $26.09; Price above EMA 50
SMA 200: $17.29; Price above SMA 200
EMA 200: $19.70; Price above EMA 200

Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.

Analyst views

4 analyst ratings

Third-party analyst opinion, not a recommendation from Gotrade.

Analyst consensus:Buy

75% Buy

25% Hold

0% Sell

Analyst price target

Low: $21.00
Average: $29.75
High: $36.00

TD Cowen

Brendan Smith

Buy

Target price

$36.00

BMO Capital

Gary Nachman

Buy

Target price

$30.00

UBS

Kevin Caliendo

Hold

Target price

$21.00

Keybanc

Scott Schoenhaus

Buy

Target price

$32.00

Seasonality

Monthly price change (%)

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2021											-13.8	-6.2
2022	-20.1	+17.6	-5.5	-30.5	-1.6	+3.5	+12.8	-11.1	-9.4	-4.8	-27.1	+6.0
2023	+32.1	-13.6	+7.0	+11.8	+8.3	+42.3	+7.5	-29.5	-23.0	-21.1	+42.5	+10.2
2024	-24.7	-4.4	+0.7	-7.4	-14.8	-10.3	+18.8	-6.9	-9.7	-1.1	+25.5	-14.2
2025	+22.9	-9.7	-7.1	+36.0	-13.1	-7.2	-1.4	-0.1	+5.0	-0.8	-14.5	+4.9
2026	-22.3	-14.4	-6.5	+3.5	+22.7	+2.8	-7.6	+27.6	+49.0	-10.9	+20.4

Earnings per share

$-0.79

-

Schrodinger, Inc. Common Stock (SDGR) Stock

Key stats

Compare with SDGR

Recent news

Earnings Preview: Schrodinger, Inc. (SDGR) Q3 Earnings Expected to Decline

Earnings Preview: Schrodinger, Inc. (SDGR) Q3 Earnings Expected to Decline

Schrödinger to Present at UBS Global Healthcare Conference

Schrödinger to Present at UBS Global Healthcare Conference

Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Schrödinger to Announce Third Quarter 2026 Financial Results on November 4

Schrödinger to Announce Third Quarter 2026 Financial Results on November 4

Technical indicators

Analyst ratings

Financials

Performance

Debt & Balance Sheet

Revenue to Profit

Earnings

Latest news

Earnings Preview: Schrodinger, Inc. (SDGR) Q3 Earnings Expected to Decline

Earnings Preview: Schrodinger, Inc. (SDGR) Q3 Earnings Expected to Decline

Schrödinger to Present at UBS Global Healthcare Conference

Schrödinger to Present at UBS Global Healthcare Conference

Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Schrödinger to Announce Third Quarter 2026 Financial Results on November 4

Schrödinger to Announce Third Quarter 2026 Financial Results on November 4

Schrödinger Research Published in Nature Reveals New Insights into Lithium-Ion Battery Chemistry

Schrödinger Research Published in Nature Reveals New Insights into Lithium-Ion Battery Chemistry

Schrodinger (SDGR) Surges 7.6%: Is This an Indication of Further Gains?

Schrodinger (SDGR) Surges 7.6%: Is This an Indication of Further Gains?

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrodinger (SDGR) Soars 12.1%: Is Further Upside Left in the Stock?

Schrodinger (SDGR) Soars 12.1%: Is Further Upside Left in the Stock?

Schrödinger Announces Licensing and Collaboration Agreement with Tectora Therapeutics, a New Biotechnology Company It Co-founded to Advance Immunology and Inflammation Programs

Schrödinger Announces Licensing and Collaboration Agreement with Tectora Therapeutics, a New Biotechnology Company It Co-founded to Advance Immunology and Inflammation Programs

Schrödinger to Present at Morgan Stanley Global Healthcare Conference

Schrödinger to Present at Morgan Stanley Global Healthcare Conference

About Schrodinger, Inc. Common Stock

Key Executives

Fundamentals

Valuation

Profitability

Trading

Technical indicators

Analyst views

Seasonality

Compare stocks

Market cap

Price / Earnings ratio

Price / Sales ratio

Dividend yield

Average volume

Earnings per share

Stocks in the same sector

FAQ

Trade Faster. Easier. Smarter.

#ReadyGoTrade